AI Summary & Key Takeaways
AI InsightConclusions: This case is important in that it not only contributes to the ongoing debate in the literature that androgen steroids may be a risk factor for CSC formation, but also draws attention to the fact that in addition to known side effects drugs used for doping may have side effects that have not yet been reported.
📌 3 Key Takeaways
Abstract
Purpose: The androgenic steroids drostanolone, boldenone, and stanozolol are used off-label by athletes for doping. This is the second case reported in the literature who used these steroids as doping for bodybuilding and developed central serous chorioretinopathy (CSC) Cased presentation: A man aged 37 years presented with symptoms of unilateral metamorphopsia, slight central scotoma, and vision loss. The anamnesis revealed that the patient used steroids (drostanolone enanthate, boldenone undecylenate and stanozolol) for body building. He was diagnosed as having bilateral CSC. The symptoms were relieved in 2 months with of topical nepafenac treatment. Although the patient discontinued androgen steroids, recurrence of CSC observed 6 months later. Conclusions: This case is important in that it not only contributes to the ongoing debate in the literature that androgen steroids may be a risk factor for CSC formation, but also draws attention to the fact that in addition to known side effects drugs used for doping may have side effects that have not yet been reported.